skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Peter, I'm interested in increasing my gold exposure in registered accounts for diversification purposes and would appreciate your latest take on the gold royalty company Sandstorm (SSL-T, SAND-N) in the wake of today's announcement of record production in Q4 2016. I have heard good things about its CEO Nolan Watson.

Thanks for your great work.
Read Answer Asked by David on January 12, 2017
Q: I know you took this company out of your growth portfolio, but since the US election this stock is been going up. I went onto there web site and listened to the Bloomberg and Bnn interviews and i love what they are doing, they seem to be light years ahead of conventional construction, and this has to be the future. With 80 % of there business in the USA and expanding around the world, would this not qualify as a good growth company for a long term hold. Do you ever put companies back in the growth portfolio after removing them?
Thanks once again.
Read Answer Asked by eugene on January 12, 2017
Q: Based on Trump being confirmed as president in the US:
What top 3 sectors in the US and a stock in each does 5i like and the same for Canada (3 sectors and a stock in each)?
Thank you.
Read Answer Asked by George on January 12, 2017
Q: I currently have HCG and WCP in the "explore" portion of a LIRA and they are both nearing break-even after holding for a relatively long period. 85% of the account is in a "core" mix of low-cost CDN, US, and Global EFTs. The remaining 15% is split evenly between HCG, WCP, and SIS. Wondering if I should sell these two positions now that they are back to my ACB and if so, what two alternatives would you recommend from a growth perspective over the next 3-5 years?
Read Answer Asked by Chris on January 12, 2017
Q: Good Morning: I hold a very small position in Enghouse and am considering an addition of shares. Your last report was in 2015 when everything seemed rosy but 2016 has seen some challenges emerge. From the Q&A section of your website I get the sense that you are still basically positive about the company. Is it your opinion that they will be able to successfully continue their acquisition strategy and who do you see as their major competitors in this area? As always, thanks for your help. Don
Read Answer Asked by Donald on January 12, 2017
Q: Hello 5i
Thanks for the service.

Checking in on a 5i current viewpoint for Timbercreek Financial.
I hold it after the merger of their two entities and really like the current 7.8% yield as income flow to Portfolio.
There has been lots going on related to interest rates and new entrants to potentially compete against TF.
Would you please offer you comments about continuing to hold this security and whether you consider any risk growing; price level and ongoing distribution?


Thanks
Dave
Read Answer Asked by David on January 12, 2017
Q: Had a very satisfactory 2016 with a combined increase in both cash & RIF accounts of 9.3%. However, TFSA has been a disaster. Initially in 2009 bought CPH & stupidly watched it run up & then way down before I dumped it for a large loss. Bought AD (second time) at around 23 - watched it climb to 31 & then crash. Sold it at $18+. I know - it's now climbing back nicely but I want to start a-fresh. Don't need the income - just lots of growth. Looking at SHOP & other similar opportunistic potentials. Your suggestions please. Thank you
Read Answer Asked by Robert on January 12, 2017
Q: Hello Peter and gang.

I read your year end review and suggestions about investing in healthcare as a theme for 2017. I'm very much an income oriented investor. I'm interested in Medical Facilities Corp. Would you say this company falls under the category of healthcare? Also what's your overall view of this company.

Thanks

Nicholas
Read Answer Asked by nicholas on January 12, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!